Family Health Centers of San Diego, INC
Family Health Centers of San Diego, INC was paid $47.71M by Medicaid between Jan 2018 and Dec 2024, across 197 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 78% of everything it billed.
SPRING VALLEY, CA 91977
Next to other Federally Qualified Health Center (FQHC) providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,336 | $6.70M | |
| 2019 | 55,566 | $5.88M | |
| 2020 | 105,036 | $7.31M | |
| 2021 | 110,351 | $7.32M | |
| 2022 | 64,944 | $5.31M | |
| 2023 | 90,408 | $7.66M | |
| 2024incomplete | 71,285 | $7.53M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 78% | 212,630 | 168,568 | $37.43M |
| 00003 | Internal/system code - not a standard HCPCS code | 21% | 42,975 | 30,494 | $10.08M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 13,877 | 11,954 | $65K |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 951 | 855 | $21K |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 138 | 110 | $15K |
| 0134A | <1% | 246 | 246 | $13K | |
| 0002A | <1% | 165 | 165 | $11K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 31,300 | 29,362 | $11K |
| 0001A | <1% | 159 | 154 | $10K | |
| 0013A | <1% | 114 | 114 | $8K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 36,983 | 34,157 | $6K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 6,332 | 5,778 | $4K |
185 more codes
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 283 | $4K |
| 98960 | <1% | 1,054 | $4K | |
| 0004A | <1% | 53 | $4K | |
| 96156 | <1% | 176 | $4K | |
| 0071A | <1% | 34 | $2K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 31 | $2K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 44 | $2K |
| G0469 | Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | <1% | 13 | $1K |
| 0011A | <1% | 20 | $1K | |
| 0072A | <1% | 18 | $1K | |
| 0012A | <1% | 17 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 12,056 | $1K |
| 90686 | <1% | 3,302 | $899.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 35 | $686.88 |
| 90756 | <1% | 1,724 | $289.00 | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 37 | $217.36 |
| 80061 | Lipid panel | <1% | 5,107 | $80.78 |
| 80053 | Comprehensive metabolic panel | <1% | 5,224 | $64.96 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 8,999 | $64.72 |
| 97803 | <1% | 6,470 | $52.22 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,347 | $44.28 |
| 86803 | <1% | 1,501 | $25.14 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,009 | $20.26 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,842 | $20.25 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,976 | $17.08 |
| 96127 | <1% | 4,563 | $14.90 | |
| 86704 | <1% | 658 | $10.71 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,866 | $10.42 |
| 86706 | <1% | 756 | $9.51 | |
| 87340 | <1% | 334 | $9.12 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,027 | $7.15 |
| 81002 | <1% | 5,078 | $6.43 | |
| 90461 | <1% | 2,332 | $6.00 | |
| 86592 | <1% | 1,887 | $3.84 | |
| 81001 | <1% | 191 | $2.77 | |
| 82570 | 0% | 710 | $0.00 | |
| 2028F | 0% | 1,504 | $0.00 | |
| 90837 | Psychotherapy session, about an hour | 0% | 433 | $0.00 |
| 99404 | 0% | 1,113 | $0.00 | |
| 90670 | 0% | 1,532 | $0.00 | |
| 81025 | 0% | 2,663 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 1,775 | $0.00 |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 398 | $0.00 |
| 90633 | 0% | 1,059 | $0.00 | |
| Z6304 | 0% | 868 | $0.00 | |
| 3078F | 0% | 1,131 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 2,348 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 1,635 | $0.00 |
| 84460 | 0% | 408 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 2,064 | $0.00 |
| 82947 | 0% | 447 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 378 | $0.00 |
| 99401 | 0% | 493 | $0.00 | |
| 99188 | 0% | 40 | $0.00 | |
| 80354 | 0% | 162 | $0.00 | |
| 84450 | 0% | 409 | $0.00 | |
| Z6400 | 0% | 1,930 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 2,545 | $0.00 |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 0% | 1,172 | $0.00 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 1,619 | $0.00 |
| 96160 | 0% | 2,198 | $0.00 | |
| 86480 | 0% | 782 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 1,171 | $0.00 |
| 90715 | 0% | 1,578 | $0.00 | |
| 90734 | 0% | 555 | $0.00 | |
| 99173 | 0% | 3,762 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 2,567 | $0.00 |
| 87210 | 0% | 1,292 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 560 | $0.00 |
| Z6414 | 0% | 46 | $0.00 | |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 1,143 | $0.00 |
| 90791 | Psychiatric diagnostic evaluation | 0% | 2,325 | $0.00 |
| Z6308 | 0% | 205 | $0.00 | |
| 92553 | 0% | 215 | $0.00 | |
| 85610 | 0% | 136 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 5,490 | $0.00 |
| Z6300 | 0% | 509 | $0.00 | |
| 81003 | 0% | 1,519 | $0.00 | |
| 90710 | 0% | 389 | $0.00 | |
| 90473 | 0% | 12 | $0.00 | |
| 90700 | 0% | 81 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 76 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 262 | $0.00 |
| 98940 | 0% | 18 | $0.00 | |
| 83540 | 0% | 189 | $0.00 | |
| 59425 | 0% | 14 | $0.00 | |
| 11721 | 0% | 255 | $0.00 | |
| 90681 | 0% | 267 | $0.00 | |
| 84439 | 0% | 64 | $0.00 | |
| 90648 | 0% | 40 | $0.00 | |
| 91313 | 0% | 221 | $0.00 | |
| 90750 | 0% | 346 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 291 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 183 | $0.00 |
| 90707 | 0% | 41 | $0.00 | |
| Z6200 | 0% | 74 | $0.00 | |
| 99442 | 0% | 33 | $0.00 | |
| 99201 | 0% | 209 | $0.00 | |
| 90653 | 0% | 20 | $0.00 | |
| A4267 | Contraceptive supply, condom, male, each | 0% | 12 | $0.00 |
| 85014 | 0% | 15 | $0.00 | |
| 82247 | 0% | 29 | $0.00 | |
| 82274 | 0% | 12 | $0.00 | |
| 59025 | Fetal non-stress test | 0% | 16 | $0.00 |
| 82248 | 0% | 16 | $0.00 | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 12 | $0.00 |
| 90380 | 0% | 14 | $0.00 | |
| 90661 | 0% | 114 | $0.00 | |
| 90658 | 0% | 12 | $0.00 | |
| H1003 | Prenatal care, at-risk enhanced service; education | 0% | 36 | $0.00 |
| 90744 | 0% | 720 | $0.00 | |
| Z6204 | 0% | 357 | $0.00 | |
| 81015 | 0% | 1,441 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 4,835 | $0.00 |
| Z6410 | 0% | 547 | $0.00 | |
| 36416 | 0% | 479 | $0.00 | |
| Z1032 | 0% | 173 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,205 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 2,551 | $0.00 |
| 3074F | 0% | 1,385 | $0.00 | |
| 82043 | 0% | 638 | $0.00 | |
| 99000 | 0% | 3,374 | $0.00 | |
| 94760 | 0% | 1,343 | $0.00 | |
| 97802 | 0% | 1,940 | $0.00 | |
| 90732 | 0% | 213 | $0.00 | |
| 97139 | 0% | 132 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 431 | $0.00 |
| 90651 | 0% | 1,586 | $0.00 | |
| 85018 | 0% | 3,992 | $0.00 | |
| 87081 | 0% | 255 | $0.00 | |
| 90619 | 0% | 342 | $0.00 | |
| 82951 | 0% | 579 | $0.00 | |
| 87070 | 0% | 193 | $0.00 | |
| Z1034 | 0% | 6,314 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 397 | $0.00 |
| 93000 | 0% | 1,551 | $0.00 | |
| 90697 | 0% | 674 | $0.00 | |
| 87428 | 0% | 691 | $0.00 | |
| 92551 | 0% | 4,526 | $0.00 | |
| 97162 | 0% | 27 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 548 | $0.00 |
| 90698 | 0% | 885 | $0.00 | |
| 90680 | 0% | 885 | $0.00 | |
| 85651 | 0% | 161 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 34 | $0.00 |
| 3008F | 0% | 320 | $0.00 | |
| 99381 | 0% | 299 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 881 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 12 | $0.00 |
| 80050 | General health panel | 0% | 31 | $0.00 |
| X4304 | 0% | 390 | $0.00 | |
| Z6406 | 0% | 331 | $0.00 | |
| 99406 | 0% | 442 | $0.00 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 0% | 303 | $0.00 |
| 90694 | 0% | 96 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 298 | $0.00 |
| 82728 | 0% | 63 | $0.00 | |
| 99402 | 0% | 327 | $0.00 | |
| 90677 | 0% | 649 | $0.00 | |
| 83550 | 0% | 128 | $0.00 | |
| 90696 | 0% | 81 | $0.00 | |
| 90674 | 0% | 45 | $0.00 | |
| Z6402 | 0% | 259 | $0.00 | |
| 99385 | 0% | 24 | $0.00 | |
| Z1038 | 0% | 68 | $0.00 | |
| 99384 | 0% | 21 | $0.00 | |
| 3079F | 0% | 18 | $0.00 | |
| 96161 | 0% | 46 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 29 | $0.00 |
| 90688 | 0% | 291 | $0.00 | |
| 99070 | 0% | 38 | $0.00 | |
| 90656 | 0% | 254 | $0.00 | |
| 99459 | 0% | 154 | $0.00 | |
| 90716 | 0% | 46 | $0.00 | |
| 99403 | 0% | 12 | $0.00 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 0% | 132 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 25 | $0.00 |
| G8433 | Screening for depression not completed, documented patient or medical reason | 0% | 37 | $0.00 |
| H0001 | Alcohol and/or drug assessment | 0% | 33 | $0.00 |
| 90381 | 0% | 29 | $0.00 | |
| 90739 | 0% | 43 | $0.00 | |
| 99441 | 0% | 26 | $0.00 | |
| 86769 | 0% | 16 | $0.00 | |
| 99383 | 0% | 17 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.